Gabriel Plotkin Covetrus, Inc. Transaction History
Melvin Capital Management LP
- $0
- Q3 2023
A detailed history of Gabriel Plotkin (Melvin Capital Management LP) transactions in Covetrus, Inc. stock. As of the latest transaction made, Melvin Capital Management LP holds 800,000 shares of CVET stock, worth $0. This represents 0.09% of its overall portfolio holdings.
Number of Shares
800,000Holding current value
$0% of portfolio
0.09%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CVET
# of Institutions
8Shares Held
72.9KCall Options Held
0Put Options Held
0-
Sarissa Consulting LLC Santa Monica, CA31.7KShares$00.68% of portfolio
-
S. Muoio & Co. LLC New York, NY30.3KShares$00.84% of portfolio
-
Eaton Vance Management Boston, MA9.79KShares$00.0% of portfolio
-
Brewin Dolphin LTD London, X0592Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,289Shares$00.0% of portfolio
About COVETRUS, INC.
- Ticker CVET
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Distribution
- Shares Outstandng 140,123,008
- Description
- Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...